Kastrati K, Sprecher M, Weber F, Langballe E, Molnar D, Göthans LT, Anderle K, Fretheim H, Jenssen Bjørkekjær H, Diep PP, Mæhlen M, Mrak D, Rempp N, Müller-Durovic B, Brunborg C, Vieira A, Correia AC, Bouillot C, Bruni C, Clarenbach C, Frauenfelder T, Aaløkken TM, Moe N, Prosch H, Midtvedt Ø, Andersson H, Studenic P, Molberg Ø, Aletaha D, Distler O et al. (2026)
Treatment patterns, disease progression and survival in Sjögren disease-associated interstitial lung disease: a multicentre European cohort study
J Autoimmun, 163, 103611 (in press)
DOI 10.1016/j.jaut.2026.103611, PubMed 42561460
Vallara R, Andersson H, Bassi I, Brunborg C, Giancotti G, Diep PP, Guerrieri A, Fretheim H, Nava S, Garen T, Poletti V, Bjørkekjær HJ, Pisani L, Langballe E, Piciucchi S, Mæhlen M, Ravaglia C, Moe N, Zompatori M, Molberg Ø, Walle J, Hoffmann-Vold AM (2026)
Clinical Profiles and Lung Function Trajectories of Patients With Idiopathic Inflammatory Myopathy Associated Interstial Lung Disease: A Comparative Study of Pulmonology and Rheumatology Settings
Chest, 170 (2), 444-456
DOI 10.1016/j.chest.2026.03.008, PubMed 41895578
Bjørkekjær HJ, Bruni C, Broch K, Brunborg C, Carreira PE, Airò P, Simeón-Aznar CP, Truchetet ME, Giollo A, Balbir-Gurman A, Martin M, Denton CP, Gabrielli A, Del Galdo F, Vonk MC, Fretheim H, Bitter H, Midtvedt Ø, Andreassen A, Høie S, Tanaka Y, Riemekasten G, Müller-Ladner U, Matucci-Cerinic M, Castellví I, Siegert E, Hachulla E, Molberg Ø, Distler O, Hoffmann-Vold AM et al. (2025)
A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis
Rheumatology (Oxford), 64 (6), 3643-3656
DOI 10.1093/rheumatology/keaf053, PubMed 39878955
Bruni C, Tofani L, Fretheim H, Liem SIE, Velauthapillai A, Bjørkekjær H, Barua I, Galetti I, Garaiman A, Becker MO, Hoffmann-Vold AM, de Vries-Bouwstra J, Vonk MC, Distler JHW, Matucci-Cerinic M, Distler O (2025)
A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC score
Rheumatology (Oxford), 64 (12), 6285-6293
DOI 10.1093/rheumatology/keaf445, PubMed 40811030
Hoffmann-Vold AM, Petelytska L, Fretheim H, Aaløkken TM, Becker MO, Jenssen Bjørkekjær H, Brunborg C, Bruni C, Clarenbach C, Diep PP, Dobrota R, Durheim MT, Elhai M, Frauenfelder T, Huang S, Jordan S, Langballe E, Midtvedt Ø, Mihai C, Mulcaire-Jones E, Pugashetti JV, Sprecher M, Oldham J, Molberg Ø, Khanna D, Distler O (2025)
Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study
Lancet Rheumatol, 7 (7), e463-e471
DOI 10.1016/S2665-9913(25)00026-8, PubMed 40381640
Scheidegger M, Boubaya M, Garaiman A, Barua I, Becker M, Bjørkekjær HJ, Bruni C, Dobrota R, Fretheim H, Jordan S, Midtvedt O, Mihai C, Hoffmann-Vold AM, Distler O, Elhai M (2024)
Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort
RMD Open, 10 (1)
DOI 10.1136/rmdopen-2023-003658, PubMed 38199606
